Efanesoctocog Alfa Shows Promise for Severe Hemophilia A Therapy
Among the benefits of treatment with this recombinant factor VIII product were fewer bleeding episodes, improved joint health, and reduced treatment burden. Replacement with factor VIII concentrate…
